![Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® (aclidinium/formoterol) for patients with Chronic Obstructive Pulmonary Disease (COPD) | Business Wire Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® (aclidinium/formoterol) for patients with Chronic Obstructive Pulmonary Disease (COPD) | Business Wire](https://mms.businesswire.com/media/20191020005073/en/750933/5/DUAKLIR_Inhaler_HighRes_ThreeQuarter_Capped_CMYK.jpg)
Circassia Pharmaceuticals launches DUAKLIR® PRESSAIR® (aclidinium/formoterol) for patients with Chronic Obstructive Pulmonary Disease (COPD) | Business Wire
Breathe Chicago Center at the University of Illinois at Chicago - Don't confuse "Rescue" and "Controller" inhalers! Although both types of inhalers treat many lungs problems and look similar, they are used
![Cannabis Science Orders First Batch Inhalation Medication and Adds CBIS MDI Rescue Inhaler for Asthma/COPD via Nebulizer, Targeting 25+ Legal States, and National Market Variables Cannabis Science Orders First Batch Inhalation Medication and Adds CBIS MDI Rescue Inhaler for Asthma/COPD via Nebulizer, Targeting 25+ Legal States, and National Market Variables](https://s.yimg.com/uu/api/res/1.2/r6xWeiCbCBmnCiHDy5tKCg--~B/aD0yODA7dz0yODA7YXBwaWQ9eXRhY2h5b24-/http://globalfinance.zenfs.com/images/US_AFTP_MarketWire_XHTML/TN-50966_CBISInhaler_original.jpg)
Cannabis Science Orders First Batch Inhalation Medication and Adds CBIS MDI Rescue Inhaler for Asthma/COPD via Nebulizer, Targeting 25+ Legal States, and National Market Variables
![Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease | Cleveland Clinic Journal of Medicine Considerations for Optimal Inhaler Device Selection in Chronic Obstructive Pulmonary Disease | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/85/2_suppl_1/S19/F1.large.jpg)